Wells Fargo & Company Journey Medical Corp Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$2.92 - $5.47 $2 - $5	1 Added 1.67%	61 $0
Q4 2023 Feb 09, 2024	BUY	$2.7 - $7.96 $10 - $31	4 Added 7.14%	60 $0
Q3 2023 Nov 13, 2023	BUY	$1.66 - $2.97 $13 - $23	8 Added 16.67%	56 $0
Q2 2023 Aug 15, 2023	BUY	$1.03 - $2.26 $2 - $4	2 Added 4.35%	48 $0
Q1 2023 May 12, 2023	BUY	$1.28 - $2.54 $2 - $5	2 Added 4.55%	46 $0
Q4 2022 Feb 13, 2023	BUY	$1.14 - $2.85 $1 - $2	1 Added 2.33%	44 $0
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.15 $34 - $58	14 Added 48.28%	43 $0
Q2 2022 Aug 12, 2022	BUY	$2.62 - $5.06 $10 - $20	4 Added 16.0%	29 $0
Q1 2022 May 16, 2022	BUY	$3.93 - $5.76 $98 - $144	25 New	25 $0

3.11M

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $75.7M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.